Managed Healthcare Executive10 小时
If Twice-Yearly Lenacapavir Could Be a HIV PrEP Game Changer, Would a Once-Yearly Version ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Applied Clinical Trials Online8 小时
Phase I Trial Supports Development of Once-Yearly Lenacapavir as Long-Acting HIV PrEP Option
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
LIC records 28% jump in group yearly renewable premiums during April-February
Life Insurance Corporation of India (LIC) recorded a 28.29 per cent surge in group yearly renewable premiums and a 7.9 per ...